IGC Pharma, Inc.

NYSEAM:IGC Stock Report

Market Cap: US$27.6m

IGC Pharma Future Growth

Future criteria checks 1/6

IGC Pharma is forecast to grow earnings and revenue by 0.1% and 10.1% per annum respectively while EPS is expected to grow by 18.6% per annum.

Key information

0.1%

Earnings growth rate

18.6%

EPS growth rate

Pharmaceuticals earnings growth23.9%
Revenue growth rate10.1%
Future return on equityn/a
Analyst coverage

Low

Last updated01 Sep 2024

Recent future growth updates

Recent updates

Does India Globalization Capital's (NYSEMKT:IGC) CEO Salary Compare Well With Industry Peers?

Feb 27
Does India Globalization Capital's (NYSEMKT:IGC) CEO Salary Compare Well With Industry Peers?

Earnings and Revenue Growth Forecasts

NYSEAM:IGC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20272-13N/A-51
3/31/20261-11N/A-62
3/31/20251-10N/A-81
9/30/20241-13-5-5N/A
6/30/20241-13-6-5N/A
3/31/20241-13-6-5N/A
12/31/20231-14-7-6N/A
9/30/20231-11-7-6N/A
6/30/20231-11-7-6N/A
3/31/20231-12-8-7N/A
12/31/20221-14-7-6N/A
9/30/20221-14-8-7N/A
6/30/20221-16-9-8N/A
3/31/20220-15-8-7N/A
12/31/20210-11-9-9N/A
9/30/20210-11-9-9N/A
6/30/20210-9-9-9N/A
3/31/20211-9-12-11N/A
12/31/20201-9-12-10N/A
9/30/20201-8-14-11N/A
6/30/20203-8-14-10N/A
3/31/20204-7-13-9N/A
12/31/20196-6-12-8N/A
9/30/20196-5-9-7N/A
6/30/20195-5-7-6N/A
3/31/20195-4-3-3N/A
12/31/20185-3-3-3N/A
9/30/20184-2-2-2N/A
6/30/20184-2N/A-2N/A
3/31/20182-2N/A-2N/A
12/31/20171-2N/A-2N/A
9/30/20171-2N/A-1N/A
6/30/20170-2N/A-2N/A
3/31/20171-2N/A-1N/A
12/31/20162-3N/A-1N/A
9/30/20163-3N/A-1N/A
6/30/20165-3N/A1N/A
3/31/20166-3N/A0N/A
12/31/20157-3N/A0N/A
9/30/20159-4N/A-1N/A
6/30/20159-4N/A-3N/A
3/31/20158-5N/A-3N/A
12/31/20145-4N/A-3N/A
9/30/20143-4N/A-3N/A
6/30/20142-4N/A-2N/A
3/31/20142-3N/A-2N/A
12/31/20134-3N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IGC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: IGC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: IGC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: IGC's revenue (10.1% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: IGC's revenue (10.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if IGC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y